Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 16594 [2017-06675]
Download as PDF
<![CDATA[
16594
Federal Register / Vol. 82, No. 64 / Wednesday, April 5, 2017 / Notices
Board of Governors of the Federal Reserve
System, March 30, 2017.
Yao-Chin Chao,
Assistant Secretary of the Board.
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jstallworth on DSK7TPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Project (SIP) 17–002,
Evaluation of the Effectiveness of
School-based Health Services
Interventions on Student Outcomes.
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, May 4, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Evaluation of the Effectiveness of
School-based Health Services
Interventions on Student Outcomes’’,
SIP 17–002.
Contact Person for More Information:
Jaya Raman, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
[FR Doc. 2017–06661 Filed 4–4–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Special Interest Project (SIP) 17–001,
Community-based Short and Longer
Term Evaluation of the Chronic Pain
Self-Management Program (CPSMP).
Time and Date: 11:00 a.m.–6:00 p.m.,
EDT, May 2, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Community-based Short and Longer
Term Evaluation of the Chronic Pain
Self-Management Program (CPSMP)’’,
SIP 17–001.
Contact Person for More Information:
Jaya Raman Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway,
Mailstop F80, Atlanta, Georgia 30341,
Telephone: (770) 488–6511, kva5@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOAs): IP17–001, Household
Transmission of Influenza Viruses in the
Community; IP17–004, Research on the
Epidemiology, Prevention and Control
of Influenza and Other Respiratory
Viruses in India; and CK17–003, Using
Influenza-like Illness-specific School
Absenteeism as an Early Warning
System for Detecting Community
Influenza.
Time and Date: 10:00 a.m.–5:00 p.m.,
EDT, May 2, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Household Transmission of Influenza
Viruses in the Community’’, IP17–001;
‘‘Research on the Epidemiology,
Prevention and Control of Influenza and
Other Respiratory Viruses in India’’,
IP17–004; and ‘‘Using Influenza-like
Illness-specific School Absenteeism as
an Early Warning System for Detecting
Community Influenza’’, CK17–003.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2017–06674 Filed 4–4–17; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2017–06675 Filed 4–4–17; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
15:11 Apr 04, 2017
Jkt 241001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 82, Number 64 (Wednesday, April 5, 2017)]
[Notices]
[Page 16594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06675]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Special Interest Project (SIP) 17-002,
Evaluation of the Effectiveness of School-based Health Services
Interventions on Student Outcomes.
Time and Date: 11:00 a.m.-6:00 p.m., EDT, May 4, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Evaluation of the Effectiveness of School-based Health Services
Interventions on Student Outcomes'', SIP 17-002.
Contact Person for More Information: Jaya Raman, Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2017-06675 Filed 4-4-17; 8:45 am]
BILLING CODE 4163-18-P
